Follow
Yiquan Wang
Title
Cited by
Cited by
Year
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
H Lv, NC Wu, OTY Tsang, M Yuan, RAPM Perera, WS Leung, RTY So, ...
Cell reports 31 (9), 2020
4382020
Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation
MM Lamers, AZ Mykytyn, TI Breugem, Y Wang, DC Wu, S Riesebosch, ...
Elife 10, e66815, 2021
882021
A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
Y Wang, M Yuan, H Lv, J Peng, IA Wilson, NC Wu
Immunity 55 (6), 1105-1117. e4, 2022
472022
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
TJC Tan, M Yuan, K Kuzelka, GC Padron, JR Beal, X Chen, Y Wang, ...
Nature Communications 12 (1), 3815, 2021
472021
Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing
Y Wang, R Lei, A Nourmohammad, NC Wu
Elife 10, e72516, 2021
192021
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
M Yuan, Y Wang, H Lv, TJC Tan, IA Wilson, NC Wu
Cell Reports 41 (7), 2022
142022
The evolutionary potential of influenza A virus hemagglutinin is highly constrained by epistatic interactions with neuraminidase
T Liu, Y Wang, TJC Tan, NC Wu, CB Brooke
Cell host & microbe 30 (10), 1363-1369. e4, 2022
12*2022
Human organoid systems reveal in vitro correlates of fitness for SARS-CoV-2 B.1.1.7
MM Lamers, TI Breugem, AZ Mykytyn, Y Wang, N Groen, K Knoops, ...
BioRxiv, 2021.05. 03.441080, 2021
112021
Mutational fitness landscape of human influenza H3N2 neuraminidase
R Lei, AH Garcia, TJC Tan, QW Teo, Y Wang, X Zhang, S Luo, SK Nair, ...
Cell reports 42 (1), 2023
82023
Egg-adaptive mutations of human influenza H3N2 virus are contingent on natural evolution
W Liang, TJC Tan, Y Wang, H Lv, Y Sun, R Bruzzone, CKP Mok, NC Wu
PLoS pathogens 18 (9), e1010875, 2022
82022
If llm is the wizard, then code is the wand: A survey on how code empowers large language models to serve as intelligent agents
K Yang, J Liu, J Wu, C Yang, YR Fung, S Li, Z Huang, X Cao, X Wang, ...
arXiv preprint arXiv:2401.00812, 2024
72024
Homologous and heterologous serological response to the N‐terminal domain of SARS‐CoV‐2 in humans and mice
H Lv, OTY Tsang, RTY So, Y Wang, M Yuan, H Liu, GK Yip, QW Teo, Y Lin, ...
European Journal of Immunology 51 (9), 2296-2305, 2021
62021
Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase
R Lei, TJC Tan, A Hernandez Garcia, Y Wang, M Diefenbacher, C Teo, ...
Nature communications 13 (1), 6443, 2022
42022
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase
R Lei, W Kim, H Lv, Z Mou, MJ Scherm, AJ Schmitz, JS Turner, TJC Tan, ...
Immunity 56 (11), 2621-2634. e6, 2023
22023
Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice
LYR Wong, A Odle, E Luhmann, DC Wu, Y Wang, QW Teo, C Ptak, ...
Mbio 14 (6), e02476-23, 2023
12023
An explainable language model for antibody specificity prediction using curated influenza hemagglutinin antibodies
Y Wang, H Lv, R Lei, YH Yeung, IR Shen, D Choi, QW Teo, TJC Tan, ...
bioRxiv, 2023
12023
Terbium complexes encapsulated in hierarchically organized hybrid MOF particles toward stable luminescence in aqueous media
Y Wang, W Zhou, F Chen, K Sun, J Zhang, E Özliseli, JM Rosenholm
CrystEngComm 20 (30), 4225-4229, 2018
12018
Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza HA stem
QW Teo, Y Wang, H Lv, TJC Tan, R Lei, KJ Mao, NC Wu
Cell reports 42 (11), 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–18